HLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma

Journal of Investigative Dermatology

Volumn 107, Issue 3, 1996, Pages 373-376

  Jackow, Clotilde M ^a   Mc Ham, Joan Breuer ^a   Friss, Allison ^a   Alvear, Joel ^a   Reveille, John R ^a   Duvic, Madeleine ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer; HLA disease association; Mycosis fungoides; Sezary syndrome

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; T CELL LYMPHOMA;

EID: 0029845356     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12363352     Document Type: Article

References (47)

1. Abel EA, Wood GS, Hoppe RT: Mycosis fungoides: clinical and histologic features, staging, evaluation, and approach to therapy. CA 43:93-113, 1993
2. Bachelez H, Bioul L, Flageal B, Bacchard M, Moulonguet-Michau I, Verola O, Morel O, Dubertret L, Sigaux F: Detection of clonal T-cell receptor gamma gene rearrangements with the use of polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sezary syndrome. Arch Dermatol 131:1027-1031, 1995
3. Bunn PA, Lamberg SI: Report of the committee on staging and classification of cutaneous T cell lymphoma. Cancer Treat Rep 63:725-728, 1979
4. Chang JCC, Smith LR, Froning KJ, Schwabe BJ, Laxer JA, Caralli LL, et al: CD8+ T cells in psoriatic lesions preferentially use T-cell receptor Vb3 and/or Vb13.1 genes. Proc Natl Acad Sci USA 91:9282-9286, 1994
5. Dubey DP, Yunis I, Leslie CA, Metha C, Yunis EJ: Homozygosity in the major histocompatibility complex region influences natural killer cell activity in man. Eur J Immunol 17:61-67, 1987
6. Duvic M, Hordinsky M, Fiedler V, O'Brien WR, Young R, Reveille J: HLA-D locus associations in alopecia areata: DRw52A may confer disease resistance. Arch Dermatol 127:64-68, 1991
7. Fischmann AB, Bunn PA Jr, Guccion JG, Matthews MJ, Minna JD: Exposure to chemicals, physical agents, and biologic agents in mycosis fungoides and the Sezary syndrome. Cancer 63:591-596, 1979
8. Ghosh SK, Abrams JT, Terunuma H, Vonderheid EC, Defreitos E: Human T cell leukemia virus type I tax/rex DNA and RNA in cutaneous T cell lymphoma. Blood 84:2663-2671, 1994
9. Gorochov G, Bachelez H, Cayuela JM, Legac E, Laroche L, Dubertret L, Sigaux F: Expression of V beta segments by Sezary cells. J Invest Dermatol 105:56-61, 1995
10. Gregersen PK: Biology of disease class II polymorphism: implications for genetic susceptibility to autoimmune disease. Lab Invest 61:5-19, 1989
11. Hall WW, Liu CR, Schneewind O, Takahashi H, Kaplan MH, Roupe G, Vahlne A: Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides. Science 253:317-319, 1991
12. Jonsson A-K, Hylding-Nielsen JJ, Servenius B, Larhammar D, Anderson G, Jorgensen F, et al: Class II genes of the human major histocompatibility complex. J Biol Chem 262:8767-8777, 1987
13. Kim YH, Bishop K, Varghese A, Hoppe RT: Prognostic factors in erythrodermic mycosis fungoides and the Sezary syndrome. Arch Dermatol 131:1003-1008, 1995
14. Kiss J, Kiss A, Toth FD, Suranyi P, Szegedi A, Rak K: Demonstration of HTLV-related proviral DNA sequences and antibodies reactive with HTLV internal proteins in an Hungarian patient with Sezary syndrome. Leukemia & Lymphoma 7:511-515, 1992
15. Kuzel TM, Roenigk HH, Rosen ST: Mycosis fungoides and the Sezary syndrome: a review of pathogenesis, diagnosis, and therapy. J Clin Oncol 9:1298-1313, 1991
16. Lee JE, Reveille JD, Ross MI, Platsoucas CO: HLA-DQB1*0301 association with increased cutaneous melanoma risk. Int J Cancer 59:510-513, 1994
17. Lessin SR, Rook AH, Rovera G: Molecular diagnosis of cutaneous T-cell lymphoma: polymerase chain reaction amplification of T-cell antigen receptor beta-chain gene rearrangements. J Invest Dermatol 96:299-302, 1991
18. Londei M, Lamb JR, Bottazzo GF, Feldmann M: Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature 312:639-641, 1984
19. MacKie R, Dick HM, DeSousa MB: HLA and mycosis fungoides. Lancet 1:1179, 1976
20. Michie SA, Abel EA, Hoppe RT, Warnke RA, Wood GS: Expression of T-cell receptor antigens in mycosis fungoides and inflammatory skin lesions. J Invest Dermatol 93:116-120, 1989
21. Naughton GK, Eisinger M, Bystryn JC: Antibodies to normal human melanocytes in vitiligo. J Exp Med 158:246-251, 1983
22. Pancake BA, Zucker-Franklin D, Coutavas EE: The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotrophic virus-associated disease. J Clin Invest 95:547-554, 1995
23. Park MS, Tonai R: Phenotype frequencies of the class II (DR, DQ) DNA alleles by the patterns of sequence-specific primer mixtures (SSPM) in four different populations and the probable haplotypes between DRB1 allele and DQB1 allele. In: Terasaki C (ed.). Clinical Transplants. Tissue Typing Laboratory, Los Angeles, 1992, pp 475-500
24. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc Natl Acad Sci USA 77:7415-7419, 1980
25. Reveille JD, Owerbach D, Goldstein R, Moreda R, Isern RA, Arnett FC: Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anti-centromere autoantibody response in systemic sclerosis (scleroderma). J Clin Invest 89:1208-1213, 1992
26. Ryder LP, Anderson L, Svejgaard A: HLA and disease registry - third report. Tissue Antigens 15:1-60, 1979
27. Safai B, Myskowski PL, Dupont B, Pollack MS: Association of HLA-DR5 with mycosis fungoides. J Invest Dermatol 80:395-397, 1983
28. Sinha AA, Lopez MT, McDevitt HO: Autoimmune diseases: the failure of self tolerance. Science 248:1380-1388, 1990
29. Skarsvag S, Hansen KE, Holst A, Moen T: Distribution of class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): an increased risk of SLE in non [DRB1*03, DQA1*0501,DQB1*0201] class II homozygotes? Tissue Antigens 40:128-133, 1992
30. Spies T, Sorrentino R, Boss JM, Okada K, Strominger JL: Structural organization of the DR subregion of the human major histocompatibility complex. Proc Natl Acad Sci USA 82:5165-5169, 1985
31. Srivastava BI, Banki K, Perl A: Human T-cell leukemia virus type I or a related retrovirus in patients with mycosis fungoides/Sezary syndrome and Kaposi's sarcoma. Cancer Res 52:4391-4395, 1992
32. Stamenkovic I, Stegagno M, Wright KA, Krane SM, Amento EP, Colvin RB, Dusquenoy RJ, Kurnick JT: Clonal dominance among T-lymphocyte infiltrates in arthritis. Proc Natl Acad Sci USA 85:1179-1183, 1988
33. Sterry W, Mielke V: CD4+ cutaneous T-cell lymphomas show the phenotype of helper/inducer T cells (CD45RA-,CDw29+). J Invest Dermatol 93:413-416, 1989
34. Szafer F, Prive VH, Oksenberg JR, Steinman L: T-cell receptor repertoire VB in alopecia areata. J Invest Dermatol 104:22-24, 1995
35. Tan H-RS, Butterworth CM, McLaughlin H, Malka S, Samman PD: Mycosis fungoides - a disease of antigen persistence. Br J Dermatol 91:607-616, 1974
36. Teixeira F, Ortiz-Plata A, Cortes-Franco R, Dominguez-Soto L: Do environmental factors play any role in the pathogenesis of mycosis fungoides and Sezary syndrome? Int J Dermatol 33:770-772, 1994
37. Tobin DJ, Orentreich N, Fenton DA, Bystryn JC: Antibodies to hair follicles in alopecia areata. J Invest Dermatol 102:721-724, 1994
38. Trowsdale J, Ragoussis J, Campbell Duncan R: Map of the human MHC. Immunol Today 12:443-446, 1991
39. Weiss LM, Hu E, Wood GS, Moulds C, Cleary ML, Warnke R, Sklar J: Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy. N Engl J Med 313:539-544, 1985
40. Weiss LM, Wood GS, Hu E, Abel EA, Hoppe RT, Sklar J: Detection of clonal T-cell receptor gene rearrangements in the peripheral blood of patients with mycosis fungoides/Sezary syndrome. J Invest Dermatol 92:601-604, 1989
41. Welsh EA, Clark HH, Epstein SZ, Reveille JD, Duvic M: Human leukocyte antigen-DQB01*03 alleles are significantly associated with alopecia areata. J Invest Dermatol 103:758-763, 1994
42. Weyland CM, Oppitz U, Hicok K, Goronzy JJ: Selection of T cell receptor V beta elements by HLA-DR determinants predisposing to rheumatoid arthritis. Arthritis Rheum 35:990-998, 1992
43. Whittemore AS, Holly EA, Lee I-M, Abel EA, Adams RM, Nickoloff BJ, Bley L, Peters JM, Gibney C: Mycosis fungoides in relation to environmental exposures and immune response: a case-control study. J Natl Cancer Inst 81:1560-1567, 1989
44. Wieselthier JS, Koh HK: Sezary syndrome: diagnosis, and critical review of treatment options. J Am Acad Dermatol 22:381-401, 1990
45. Wood GS, Tung RM, Haeffner AC, Crooks CF, Liao S, Orozco R, Veelken H, Kadin ME, Koh H, Heald P, Barnhill RL, Sklar J: Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis. J Invest Dermatol 103:34-41, 1994
46. Zucker-Franklin D, Coutavas EE, Rush MG, Zouzar DC: Detection of human T-lymphotrophic virus-like particles in cultures of peripheral blood lymphocytes from patients with mycosis fungoides. Proc Natl Acad Sci USA 88:7630-7634, 1991
47. Zucker-Franklin D, Hooper WC, Evatt BL: Human lymphotropic retroviruses associated with mycosis fungoides: evidence that human T-cell lymphotropic virus type II as well as HTLV-1 may play a role in the disease. Blood 80:1537-1545, 1992